EGFR and lung carcinoma: In the past decades, several membrane-located proteins were discovered that could successfully be targeted, i.e. estrogen/progesterone receptor (ER/PR) in breast cancer patients and epidermal growth factor receptor (EGFR) in lung cancer patients [2, 3].